Vaxxinity, Inc. (VAXX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jul 30, 2026, 4:00 PM EST
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $25.35 thousand as of July 31, 2026. Its market cap has decreased by -99.00% in one year.
Market Cap
25.35K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since November 11, 2021, Vaxxinity's market cap has decreased from 2.08B to 25.35K, a decrease of -100.00%. That is a compound annual growth rate of -90.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 25.35K | -33.33% |
| Dec 31, 2025 | 38.02K | -94.00% |
| Dec 31, 2024 | 633.74K | -99.41% |
| Dec 29, 2023 | 107.73M | -38.95% |
| Dec 30, 2022 | 176.48M | -74.91% |
| Dec 31, 2021 | 703.46M | -66.12% |
| Nov 11, 2021 | 2.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Panbela Therapeutics | 53.89K |
| Nanobac Pharmaceuticals | 24.95K |
| Scorpius Holdings | 24.46K |
| IO Biotech | 21.59K |
| Scopus BioPharma | 21.04K |
| Health Sciences Group | 20.51K |
| Regenicin | 15.35K |
| Statera Biopharma | 14.52K |